Work

Phase I pharmacokinetic and pharmacodynamic study of the inhibitor of activation of AKT (p-Akt), triciribine phosphate monohydrate (TCN-PM), in solid malignancies

Year: 2007

Type: article

Study design: Clinical Trial

Source: Molecular Cancer Therapeutics

Authors: Christopher R. Garrett, Domenico Coppola, Robert M. Wenham, Christopher L. Cubitt, Anthony Neuger, Timothy J. Frost, Daniel M. Sullivan, Jin Q. Cheng, Saı̈d M. Sebti

Institution: Moffitt Cancer Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2550374956

FWCI:

Cites:

Cited by:

Related to: 10